Platov - New Eastern Outlook
experts are saying that the biggest flaw of Big Pharma today is a high percentage
of ineffective products being sold without previous clinical trials. This
is particularly true when anti-cancer medications are concerned.The sad
fact is that Big Pharma prefers to invest in advertising and bribing officials
instead of attempting to make their products truly effective. Today pharmaceutical
manufacturing is handsomely funded by politicians and organized crime, since
it’s has become one of the most efficient money laundering schemes
and has already corrupted a large number of US and EU officials.
expert C. Glenn Begley, the former Vice-President and Global Head of Hematology
and Oncology Research at Amgen – one of the largest cancer research
centers in the US, is now a senior vice president in a private biotech company
TetraLogic. In his article published in Nature magazine back in March 2012,
Glenn stated that a series of tests conducted under his supervision proved
that out of 53 anti-cancer drugs that had been developed by “respected
laboratories,” a total of 47 showed no noticeable improvements in
patients’ health conditions (which amounts to 88%).
this study was proven right by a number of research teams that arrived at
similar results while running tests. In 2009, a group of researchers at
Michigan State University reached a similar conclusion, just like Bayer‘s
research team. At the same time certain research institutes, like the famous
Harvard Medical School, prefer to falsify their studies. In Harvard’s
case it received a hefty grant of 15 million dollars from the Federal government.
Parma is all about PR campaigns and advertisements, while putting new potentially
dangerous drugs on the market. For example, Glivec and Sutent that are authorized
for usage in Europe, are reducing the size of tumors by wiping out pericytes
that prevent the growth of tumor-nourishing blood vessels. As a result,
additional testings showed, these drugs force cancer to spread faster across
a body, making it increasingly more deadly.
Professor at the Department of Pharmacology at Dalhousie University, George
S. Robertson is also stressing the ineffectiveness of certain drugs that
are being put on the market today.
the past two decades, the most promising drugs that should have allowed
people to fight cancer effectively were Gleevec and Herceptin. However,
as it has been recently discovered, each of these medications initiated
genetic mutations of cells, by turning a regular one into a malignant cell.
from Bayer had little luck with their studies as well. In 2011, in a paper
“Believe it or not”, Bayer admitted that researchers couldn’t
get the same results in clinical trials on stage two of their testings.
The head of Target Discovery at Bayer Schering Pharma admitted that research
teams couldn’t replicate the initial results of most of Bayer’s
studies, no matter how hard they tried. Out of 47 potential new anti-cancer
drugs less than one-quarter got past stage two. The scandal that followed
put an end to all anti-cancer studies at Bayer.
to C. Glenn Begley, when investigating Amgen Inc, approximately 100 scientists
could not confirm the official results of clinical trials they contacted
the producers of these drugs. Some of them demanded that Amgen Inc should
sign a non-disclosure agreement in order to keep these facts from being
of federal grants Big Pharma is falsifying research, by paying for factless
publications in scientific journals, which then opens a direct path to the
introduction of new drugs on the market, regardless of their potential danger.
Unfortunately, regular people across the globe are to pay for this deceit,
more often than not with their own lives.